Novo Nordisk A/S NOVOb.CO:
U.S. FEDERAL TRADE COMMISSION SAYS IT HAS CONCERNS ABOUT NOVO NORDISK BID FOR METSERA - FTC LETTER TO METSERA
FTC IS CONCERNED ABOUT NOVO-METSERA DEAL PROCEEDING WITHOUT FILING FOR HART-SCOTT-RODINO ANTITRUST CLEARANCE
FTC SAYS IT HAS NO POSITION ON WHETHER THE PROPOSED NOVO-METSERA TRANSACTION ABIDES BY ANTITRUST LAW
US SAYS STRUCTURE OF NOVO NORDISK TRANSACTION MAY REDUCE METSERA'S INCENTIVE TO CONTINUE BRINGING DRUGS TO MARKET